Search

Christopher R. Stone

Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1614, 1628, 4173
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8294451 [patent_doc_number] => 08222240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome' [patent_app_type] => utility [patent_app_number] => 12/328052 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12905 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12328052 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/328052
Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome Dec 3, 2008 Issued
Array ( [id] => 5272346 [patent_doc_number] => 20090076122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'PARP Modulators and Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/326798 [patent_app_country] => US [patent_app_date] => 2008-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12974 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076122.pdf [firstpage_image] =>[orig_patent_app_number] => 12326798 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/326798
PARP Modulators and Treatment of Cancer Dec 1, 2008 Abandoned
Array ( [id] => 5575948 [patent_doc_number] => 20090143310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Method of stimulating the motility of the gastrointestinal system using ipamorelin' [patent_app_type] => utility [patent_app_number] => 12/313956 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20888 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143310.pdf [firstpage_image] =>[orig_patent_app_number] => 12313956 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/313956
Method of stimulating the motility of the gastrointestinal system using ipamorelin Nov 25, 2008 Issued
Array ( [id] => 6600965 [patent_doc_number] => 20100292334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/744013 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292334.pdf [firstpage_image] =>[orig_patent_app_number] => 12744013 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744013
N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS Nov 18, 2008 Abandoned
Array ( [id] => 8920991 [patent_doc_number] => 08486926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Steroid tetrol solid state forms' [patent_app_type] => utility [patent_app_number] => 12/272767 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26581 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12272767 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/272767
Steroid tetrol solid state forms Nov 16, 2008 Issued
Array ( [id] => 5452227 [patent_doc_number] => 20090068264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate' [patent_app_type] => utility [patent_app_number] => 12/268244 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10110 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068264.pdf [firstpage_image] =>[orig_patent_app_number] => 12268244 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/268244
Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate Nov 9, 2008 Abandoned
Array ( [id] => 5474371 [patent_doc_number] => 20090247537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHODS FOR PREVENTING OR TREATING BRUXISM USING DOPAMINERGIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/264806 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6225 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247537.pdf [firstpage_image] =>[orig_patent_app_number] => 12264806 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/264806
METHODS FOR PREVENTING OR TREATING BRUXISM USING DOPAMINERGIC AGENTS Nov 3, 2008 Abandoned
Array ( [id] => 5447092 [patent_doc_number] => 20090048318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES' [patent_app_type] => utility [patent_app_number] => 12/256669 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17085 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048318.pdf [firstpage_image] =>[orig_patent_app_number] => 12256669 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/256669
METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES Oct 22, 2008 Abandoned
Array ( [id] => 5385177 [patent_doc_number] => 20090226422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Chemical Inhibitors of Inhibitors of Differentiation' [patent_app_type] => utility [patent_app_number] => 12/253009 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27630 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226422.pdf [firstpage_image] =>[orig_patent_app_number] => 12253009 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/253009
Chemical inhibitors of inhibitors of differentiation Oct 15, 2008 Issued
Array ( [id] => 5285562 [patent_doc_number] => 20090099237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Methods of treating inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 12/287605 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7624 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099237.pdf [firstpage_image] =>[orig_patent_app_number] => 12287605 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/287605
Methods of treating inflammatory diseases Oct 9, 2008 Abandoned
Array ( [id] => 5265655 [patent_doc_number] => 20090118340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers' [patent_app_type] => utility [patent_app_number] => 12/287671 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4509 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118340.pdf [firstpage_image] =>[orig_patent_app_number] => 12287671 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/287671
Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers Oct 8, 2008 Abandoned
Array ( [id] => 5480675 [patent_doc_number] => 20090203632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CONTRACTURE' [patent_app_type] => utility [patent_app_number] => 12/247840 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 53805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203632.pdf [firstpage_image] =>[orig_patent_app_number] => 12247840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/247840
COMPOSITIONS AND METHODS FOR TREATING CONTRACTURE Oct 7, 2008 Abandoned
Array ( [id] => 6267652 [patent_doc_number] => 20100298393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors' [patent_app_type] => utility [patent_app_number] => 12/678477 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6868 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298393.pdf [firstpage_image] =>[orig_patent_app_number] => 12678477 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678477
Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors Sep 16, 2008 Abandoned
Array ( [id] => 6054598 [patent_doc_number] => 20110110958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA' [patent_app_type] => utility [patent_app_number] => 12/677705 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 25388 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110958.pdf [firstpage_image] =>[orig_patent_app_number] => 12677705 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677705
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA Sep 10, 2008 Abandoned
Array ( [id] => 8352068 [patent_doc_number] => 08247397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use' [patent_app_type] => utility [patent_app_number] => 12/208227 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 67 [patent_no_of_words] => 47191 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12208227 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/208227
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use Sep 9, 2008 Issued
Array ( [id] => 6350370 [patent_doc_number] => 20100249119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'HETEROCYCLIC COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/675663 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 167252 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249119.pdf [firstpage_image] =>[orig_patent_app_number] => 12675663 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/675663
Heterocyclic compound and use thereof Aug 27, 2008 Issued
Array ( [id] => 6016722 [patent_doc_number] => 20110224195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/672100 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21556 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224195.pdf [firstpage_image] =>[orig_patent_app_number] => 12672100 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672100
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Aug 17, 2008 Issued
Array ( [id] => 4853215 [patent_doc_number] => 20080318958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'New utilities of tricyclic compounds' [patent_app_type] => utility [patent_app_number] => 12/222773 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15021 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318958.pdf [firstpage_image] =>[orig_patent_app_number] => 12222773 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/222773
New utilities of tricyclic compounds Aug 14, 2008 Abandoned
Array ( [id] => 6048637 [patent_doc_number] => 20110207729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'BICYCLIC ACYLGUANIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/672277 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27331 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207729.pdf [firstpage_image] =>[orig_patent_app_number] => 12672277 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672277
BICYCLIC ACYLGUANIDINE DERIVATIVE Aug 6, 2008 Abandoned
Array ( [id] => 8016341 [patent_doc_number] => 08137669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Elimination of heterogeneous or mixed cell population in tumors' [patent_app_type] => utility [patent_app_number] => 12/186411 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 20827 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137669.pdf [firstpage_image] =>[orig_patent_app_number] => 12186411 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/186411
Elimination of heterogeneous or mixed cell population in tumors Aug 4, 2008 Issued
Menu